Microarray Analysis - Global Strategic Business Report 2026: Secure Share in a $5.1 Billion Market by 2032, Featuring Profiles of Key Players Agilent, Illumina, Roche and Thermo Fisher

What happened: ResearchAndMarkets.com added the "Microarray Analysis - Global Strategic Business Report 2026" to its offering, covering market forecasts through 2032 and profiles of key players including Agilent, Illumina, Roche and Thermo Fisher. Key numbers: Market valued at US$3.3 billion in 2025, projected to Why it matters: The report attributes growth to expanding genomics research, rising demand for personalized medicine, increased use of molecular diagnostics, and continued investment in drug discovery, with personalized medicine cited as a significant opportunity for the market. Market: +1.0% today ($178.69), +30.1% YTD, 0.3x vol — as of 17:33 UTC

ResearchAndMarkets.com added the "Microarray Analysis - Global Strategic Business Report 2026" to its offering, covering market forecasts through 2032 and profiles of key players including Agilent, Illumina, Roche and Thermo Fisher.

The report attributes growth to expanding genomics research, rising demand for personalized medicine, increased use of molecular diagnostics, and continued investment in drug discovery, with personalized medicine cited as a significant opportunity for the market. Market: +1.0% today ($178.69), +30.1% YTD, 0.3x vol — as of 17:33 UTC